Massive Bio Company
Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.
Investors
Founded Date:
2015-05-04
Last Funding Type:
Venture - Series Unknown
Headquarters:
New York, New York, United States
Investors Number:
13.0
Technology:
['BioTech & HealthTech']
Employee Number:
11-50
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-06-02
Funding Status:
Early Stage Venture
Investor Type:
support@massivebio.com
Total Funding:
137650394